Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)
ready to TALK MICROBIOME?
Reach out to our team with any questions about BiomeDx. We're here to support your understanding of our platform and services.